highMechanism

Constitutive inflammasome activation in CAPS mutants characterized

Cryopyrin-Associated Periodic Syndromes →

Summary

Molina-López et al. (2024) demonstrated that CAPS-associated NLRP3 variants form constitutively active inflammasomes with basal gasdermin D cleavage, IL-18 release, and pyroptosis, responsive to MCC950 inhibitor (Nat Commun).

Related genes

NLRP3Multiple pathogenic variants (>250)
Gain-of-function mutations causing constitutive inflammasome activation. Most in exon 3 (NACHT domain).
NLRP3R260W
Most frequent MWS-associated variant in French population.
NLRP3T348M
Associated with early onset, chronic course, hearing loss.
NLRP3Somatic mosaicism variants
Low-level allele frequency (1.9–45%); can increase over time. Explains 'mutation-negative' CAPS.
NLRP3De novo mutations
Spontaneous new mutations; no family history.
NLRP3Y861 LRR domain variants
Atypical phenotype with minimal cold-triggered rash.

More from Cryopyrin-Associated Periodic Syndromes

mediumClinical trial

Oral NLRP3 inhibitor dapansutrile enters clinical trials for CAPS

mediumGenetic discovery

Deep sequencing reveals somatic mosaicism in 40% of mutation-negative CAPS children

mediumDiagnostic advance

Cryo-sensitive aggregation mechanism explains cold-triggered FCAS

ID: cryopyrin-associated-periodic-syndromes-update-0Type: mechanismImpact: high